Smith M, Piulats J, Todenhofer T, Lee JL, et al. Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2025;26:1489-1500.
PMID: 41167216